Knowledge about antipsychotic long-acting injections: Bridging that gap

British Journal of Psychiatry

Volumn 195, Issue SUPPL. 52, 2009, Pages

  Burns, Tom ^a  

^a WARNEFORD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPSYCHOTIC LONG ACTING INJECTION AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; LONG ACTING DRUG; NEUROLEPTIC AGENT; OLANZAPINE; PERPHENAZINE; UNCLASSIFIED DRUG;

AUSTRALIA; DRUG FORMULATION; HUMAN; INJECTION; LONG TERM CARE; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRESCRIPTION; PSYCHOPHARMACOLOGY; PSYCHOSIS; REVIEW; SCHIZOPHRENIA; TREATMENT INDICATION; UNITED KINGDOM; ATTITUDE TO HEALTH; DELAYED RELEASE FORMULATION; EDITORIAL;

ANTIPSYCHOTIC AGENTS; DELAYED-ACTION PREPARATIONS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INJECTIONS; MEDICATION ADHERENCE; PSYCHOTIC DISORDERS;

EID: 71249099850     PISSN: 00071250     EISSN: 14721465     Source Type: Journal    
DOI: 10.1192/bjp.195.52.s5     Document Type: Review

References (11)

1. Taylor D. Psychopharmacology and adverse effects of antipsychotic long-acting injections. Br J Psychiatry 2009; 195 (suppl 52): s13-9.
2. Haddad PM, Taylor M, Niaz OS. First-generation antipsychotic long-acting injections v. oral antipsychotics in schizophrenia: systematic review of randomised controlled trials and observational studies. Br J Psychiatry 2009; 195 (suppl 52): s20-8.
3. Fleischhacker WW. Second-generation antipsychotic long-acting injections: systematic review. Br J Psychiatry 2009; 195 (suppl 52): s29-36.
4. Barnes TRE, Shingleton-Smith A, Paton C. Antipsychotic long-acting injections: prescribing practice in the UK. Br J Psychiatry 2009; 195 (suppl 52): s37-42.
5. Tiihonen J, Walhbeck K, Lönnqvist J, Klaukka T, Ioannidis JP, Volavka J, et al. Effectiveness of antipsychotic treatments in a nationwide cohort of patients in community care after first hospitalisation due to schizophrenia and schizoaffective disorder: observational follow-up study. BMJ 2006; 333: 224-227
6. Kane JM, Garcia-Ribera C. Clinical guideline recommendations for antipsychotic long-acting injections. Br J Psychiatry 2009; 195 (suppl 52): s63-7.
7. Johnson DAW. Historical perspective on antipsychotic long-acting injections. Br J Psychiatry 2009; 195 (suppl 52): s7-12.
8. Wooff K, Goldberg DP. Further observations on the practice of community care in Salford. Differences between community psychiatric nurses and mental health social workers. Br J Psychiatry 1988; 153: 30-37 (Pubitemid 18171060)
9. Gray R, Spilling R, Burgess D, Newey T. Antipsychotic long-acting injections in clinical practice: medication management and patient choice. Br J Psychiatry 2009; 195 (suppl 52): s51-6.
10. Waddell L, Taylor M. Attitudes of patients and mental health staff to antipsychotic long-acting injections: systematic review. Br J Psychiatry 2009; 195 (suppl 52): s43-50.
11. Lambert TJ, Singh BS, Patel MX. Community treatment orders and antipsychotic long-acting injections. Br J Psychiatry 2009; 195 (suppl 52): s57-62.